Imperial Ginseng Products Ltd.
Imperial Ginseng Products Ltd. Fundamental Analysis
Imperial Ginseng Products Ltd. (IGPFF) shows weak financial fundamentals with a PE ratio of -93.74, profit margin of 0.00%, and ROE of -38.69%. The company generates N/A in annual revenue with weak year-over-year growth of -1.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -108.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IGPFF's fundamental strength across five key dimensions:
Efficiency Score
WeakIGPFF struggles to generate sufficient returns from assets.
Valuation Score
ModerateIGPFF shows balanced valuation metrics.
Growth Score
WeakIGPFF faces weak or negative growth trends.
Financial Health Score
ExcellentIGPFF maintains a strong and stable balance sheet.
Profitability Score
WeakIGPFF struggles to sustain strong margins.
Key Financial Metrics
Is IGPFF Expensive or Cheap?
P/E Ratio
IGPFF trades at -93.74 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, IGPFF's PEG of 8.67 indicates potential overvaluation.
Price to Book
The market values Imperial Ginseng Products Ltd. at 40.86 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 2458.52 times EBITDA. This signals the market has high growth expectations.
How Well Does IGPFF Make Money?
Net Profit Margin
For every $100 in sales, Imperial Ginseng Products Ltd. keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-38.69 in profit for every $100 of shareholder equity.
ROA
Imperial Ginseng Products Ltd. generates $-36.53 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $-0.02 in free cash annually.
FCF Yield
IGPFF converts -2.05% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-93.74
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
8.67
vs 25 benchmark
P/B Ratio
Price to book value ratio
40.86
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.00
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
6.18
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.39
vs 25 benchmark
ROA
Return on assets percentage
-0.37
vs 25 benchmark
ROCE
Return on capital employed
-0.45
vs 25 benchmark
How IGPFF Stacks Against Its Sector Peers
| Metric | IGPFF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -93.74 | 22.36 | Better (Cheaper) |
| ROE | -38.69% | 1238.00% | Weak |
| Net Margin | 0.00% | -5096.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 1.23 | Strong (Low Leverage) |
| Current Ratio | 6.18 | 2.47 | Strong Liquidity |
| ROA | -36.53% | -191995.00% (disorted) | Weak |
IGPFF outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Imperial Ginseng Products Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-100.00%
Industry Style: Defensive, Dividend, Low Volatility
DecliningEPS CAGR
104.00%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthFCF CAGR
-225.67%
Industry Style: Defensive, Dividend, Low Volatility
Declining